GENEART
LIVE

Serial Number

76118143

Owner

Geneart GmbH

Attorney

Kenya Williams

Filing Date

Aug 28, 2000

Add to watchlist:

No watchlists yet
View on USPTO

GENEART Trademark

Serial Number: 76118143 • Registration: 2751683

GENEART is a trademark filed by Geneart GmbH on August 28, 2000. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Geneart GmbH (5 trademarks)

Josef-Engert-Str. 9
D-93053 Regensburg , DE

Entity Type: 03

THERMO FISHER SCIENTIFIC GENEART GMBH (4 trademarks)

SANTA CLARA, CA 95051

Entity Type: 16

Geneart AG (7 trademarks)

Josef-Engert-Str. 11
Regensburg 93053 , DE

Entity Type: 03

Trademark Details

Filing Date

August 28, 2000

Registration Date

August 19, 2003

Published for Opposition

May 27, 2003

Goods & Services

[ Scientific and laboratory equipment, namely, automatic machines for the synthesis of desoxyribonucleinic acids; robot machines for laboratory purposes ]

[ Medicines for human-medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; medicines for dental purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, Alzheimer's and infectious diseases; medicines for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; bacteriological preparations for medical and veterinary purposes for use in the treatment of cancer, high blood pressure, diarrhea, skin irritations, infections, diabetes, autoimmune diseases and arthritis as well as for use in genetherapy; biological preparations for medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; biological preparations for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; germicides for medical and laboratory equipment, institutional, domestic uses; vermicides for medical and laboratory equipment, institutional, domestic, residential uses; fungicides for medical and laboratory equipment, institutional, domestic uses; biological materials for medical diagnostic laboratories, namely, proteins, DNA, RNA and modifications thereof; diagnostic materials for clinical and medical laboratory purposes, namely, proteins, DNA, RNA and modifications thereof ]

Chemical preparations for laboratory analysis in the field of biotechnology, drug discovery, genomics, molecular biology and microbiology; chemical preparations for scientific purposes in the field of biotechnology, drug discovery, genomics, molecular biology and microbiology; bacteria preparations for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; bacteriological preparations for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; micro-organism cultures for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; biochemical catalysts for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; biological materials of scientific and research laboratories, namely, proteins, DNA, RNA and modifications thereof; diagnostic materials for scientific and research purposes, namely, proteins, DNA, RNA and modifications thereof; enzymes and enzyme preparations for use in the field of food manufacture, waste treatment, fermentation, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds

[ computer services, namely, updating of computer software, consulting, designing computer software, maintenance of computer software, leasing of computer software, leasing of access time to subscribers to computer databases in the field of medicines, pharmaceuticals, genomics, developing data processing programs, leasing of data processing apparatus, recomposition of computer data; ] chemical analyses; research in the field of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, machine engineering; laboratory services in the fields of bacteriology, chemistry, professional advice in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, machine engineering; consultation in the field of pharmacy; [ measuring calibration; ] development and research of new products for others; [ environmental protection consulting; patent services, namely, patent right management, exploitation in nature of consultation, licensing; ] technical project planning and adaption services in the field of bacteriology, biology, chemistry, physics, genealogy, cosmetics, engineering, machine engineering; and quality control for others

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Feb 19, 2024 NAS8
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Feb 18, 2024 RNL2
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
Feb 18, 2024 9G8P
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
Feb 18, 2024 8PRT
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 18, 2024 APRE
TEAS SECTION 8 & 9 RECEIVED
Aug 24, 2023 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 19, 2022 REM2
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 2, 2016 ASGN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 23, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 23, 2014 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Aug 27, 2012 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Aug 27, 2012 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Aug 27, 2012 89AG
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 24, 2012 TCCA
TEAS SECTION 8 & 9 RECEIVED
Aug 24, 2012 E89R
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 21, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 21, 2011 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 2, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 2, 2011 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 1, 2011 TCCA
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 16, 2009 C15P
ASSIGNED TO PARALEGAL
Jul 27, 2009 PLGL
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Jul 21, 2009 815F
TEAS SECTION 8 & 15 RECEIVED
Jul 21, 2009 E815
CASE FILE IN TICRS
Jan 29, 2008 CFIT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 9, 2006 TCCA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 13, 2006 ASGN
REGISTERED-PRINCIPAL REGISTER
Aug 19, 2003 R.PR
PUBLISHED FOR OPPOSITION
May 27, 2003 PUBO
NOTICE OF PUBLICATION
May 7, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 2, 2002 CNSA
Sec. 1(B) CLAIM DELETED
Nov 1, 2002 1.BD
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 15, 2002 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2002 CNSA
ASSIGNED TO EXAMINER
May 9, 2002 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 14, 2002 CRFA
PAPER RECEIVED
Mar 14, 2002 MAIL
NON-FINAL ACTION MAILED
Sep 13, 2001 CNRT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 6, 2001 CRFA
NON-FINAL ACTION MAILED
Jan 30, 2001 CNRT
ASSIGNED TO EXAMINER
Jan 18, 2001 DOCK